Reflow Medical

Focus: Reflow Medical is an early-stage medical device company (founded 2024) headquartered in San Clemente, CA, specializing in catheters and related products for cardiovascular and peripheral vascular interventions. With 1-50 employees and recently achieving public status, it is a pre-commercial innovator in minimally invasive vascular access.

Unknown Cardiovascular

Profile data last refreshed 9h ago · AI intelligence enriched 1w ago

Funding Stage

PUBLIC

Employees

1-50

Open Jobs

17-1 this month

Stable — net -1 jobs in 30d

5 added, 6 removed. Backfill posture.

Should You Work at Reflow Medical?

AI assessment

Best suited for risk-tolerant early-stage operators seeking equity upside and high-impact vascular device development; unsuitable for candidates prioritizing financial stability, established infrastructure, or near-term product revenue.

Why Work Here

Ground-floor opportunity: company founded in 2024 with recently announced product launches (next-gen torqueable microcatheters, July 2026) and active patient enrollment in clinical trials for novel spur stent systems.

Data completeness

4/9 — Basic

Company HealthStrong

Pipeline

Mid-stage

1 Phase 3+

LOE Risk

Protected

No near-term cliffs

Hiring

Stable

Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.

Pipeline & Clinical Trials

Below the Knee peripheral intervention

Critical Limb Ischemia

N/A

Clinical Trials (1)

NCT03669458Feasibility Clinical Trial Using the SPUR System to Demonstrate Safety and Efficacy.

N/A

Help build intelligence for Reflow Medical

No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.

Share Interview Share Compensation

Data Sources

Drug label: DailyMed / FDA
Clinical trials: ClinicalTrials.gov
Patent data: FDA Orange Book
Spending data: CMS Medicare

The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.

Diverse pipeline spanning high-impact indications: 9 programs targeting peripheral arterial disease, critical limb ischemia, in-stent restenosis, and coronary occlusions, with coraFlex catheter in Phase 3 and potential near-term regulatory catalysts.

Aggressive hiring phase: 17 active job openings with IT (8), Commercial (4), and Customer Success (2) roles indicate scaling preparation ahead of product launches and market entry.

Watch Out For

Extreme early-stage risk: Founded in 2024 with publicly available financials, revenue data, and R&D spend all unknown; no clarity on funding model, cash runway, or path to profitability.
Minimal track record: only 2 publications and no FDA approvals or PDUFA dates visible; clinical trial activity suggests early development stage with long timelines to commercialization and uncertain regulatory success.

Generated by Claude from Reflow Medical's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.

Drug Eluting Temporary Spur Stent System

Critical Limb Ischemia

N/A

Clinical Trials (1)

NCT06122974Drug Eluting Temporary Spur Stent System vs Percutaneous Balloon Angioplasty for the Treatment of Critical Limb Ischemia

N/A

Wingman Crossing Catheter

Chronic Total Occlusion of Artery of the Extremities

N/A

Clinical Trials (1)

NCT03403426ReFlow Medical Wingman Catheter Wing-IT Clinical Trial

N/A

Vessel recoil measurement 15 minutes post final treatment

Chronic Limb Threatening Ischemia

N/A

Clinical Trials (1)

NCT07465627Vessel Recoil in Specific CLTI Populations

N/A

Temporary Spur Stent System

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT03807531A Study of the Temporary Spur Stent for the Treatment of Narrowing and Blockages in the Arteries Below the Knee

N/A

Temporary Spur Stent System

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT04162418A Study of the TEmporary Spur StEnt System for the Treatment of Lesions Located in the InfraPoplitEal ARteries Using a LIMUS-base DCB

N/A

Bare Temporary Spur Stent System

Peripheral Arterial Disease

N/A

Clinical Trials (1)

NCT05358353A Prospective Single-Arm Multicenter StuDy of the BarE TEmporary SPur StEnt System foR the tREatment of Vascular Lesions Located in the infrapoplitEal Arteries beLow the Knee (DEEPER REVEAL)

N/A

Drug-eluting Coronary Spur Stent System

In-stent Restenosis

PHASE_1

Clinical Trials (1)

NCT06117150Pilot Study of the Coronary Spur Stent for In-stent Restenosis (DEEPER CORONARY)

Phase 1

coraFlex Catheter

Coronary Occlusion

PHASE_3

Clinical Trials (1)

NCT05848232Single-Arm Study Evaluating Use of the CORA Catheters for the Crossing of Coronary Chronic Total Occlusions

Phase 3

Interview Prep Quick Facts

Founded: 2024

Portfolio: 9 clinical trials

Top TAs: Cardiovascular

Publications: 2 in PubMed

Open Roles: 17 active jobs

Therapeutic Area Focus

Cardiovascular

1 pipeline

Marketed

Pipeline

Hiring Trend

Stable

Open Roles

Added

-0

Filled/Removed

Based on last 4 crawl cycles

Research Publications(2)

Recent peer-reviewed publications with author affiliations at this company

Early Tibial Vessel Recoil Following Treatment With the Bare Temporary Spur Stent System: Results From the DEEPER OUS Vessel Recoil Substudy.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

2026

PMID:39305087

Preclinical Evaluation of the Temporary Drug-Coated Spur Stent System in Porcine Peripheral Arteries.

Journal of endovascular therapy : an official journal of the International Society of Endovascular Specialists

2021

PMID:34278807

Pro Feature

Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.

Upgrade to Pro — $25/mo

Reflow Medical

Should You Work at Reflow Medical?

Why Work Here

Pipeline & Clinical Trials

Watch Out For

Recent News · Reflow Medical(10)

Open Jobs (17)

Founding Recruiter

Customer Success

Sales Development Representative

Fractional Product & Narrative Marketer

Fractional Head of Customer Success

Fractional Head of Sales

Hiring Trend

Research Publications(2)